Related references
Note: Only part of the references are listed.Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Andre M. Cantin et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
α1-Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses
Patrick Geraghty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Nebulized thiocyanate improves lung infection outcomes in mice
J. D. Chandler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
α1-antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice
Di Jiang et al.
RESPIRATORY RESEARCH (2013)
A Review of α1-Antitrypsin Deficiency
James K. Stoller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
SPLUNC1 Promotes Lung Innate Defense Against Mycoplasma pneumoniae Infection in Mice
Fabienne Gally et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
α1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
M. Griese et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginoso
Eric Giannoni et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease
F Rubio et al.
THORAX (2004)
Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Multiple effects of α1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness
I Zelvyte et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2003)
Effects of respiratory Mycoplasma pneumoniae infection on allerizen-induced bronchial hyperresponsiveness and lung inflammation in mice
HW Chu et al.
INFECTION AND IMMUNITY (2003)
Lung infections associated with cystic fibrosis
JB Lyczak et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Share Paper
